Israeli Cannabis Industry Enters Legal Battle to Allow Exports | CashCropToday
0 Shares 143 Views

Israeli Cannabis Industry Enters Legal Battle to Allow Exports

February 26, 2018
143 Views

Earlier this month, the Israeli Prime Minister was convinced by U.S. President Donald Trump to abandon Isreal’s plan to become one of the largest exporters of cannabis around the world. This has lead to those heavily involved in the cannabis industry in Isreal to fight back.

The opportunity for legal cannabis exports means everything for cultivators, processors, manufacturers, and investors involved in the cannabis industry in Isreal. Hagit Weinstock, the lawyer representing a coalition of cannabis business owners, believes that those involved in the industry won’t be able to sustain profits unless the export of cannabis is allowed. This has lead Weinstock to take legal action against the Israeli government
in a court case to begin this week.

Producers, manufacturers, and investors involved in the Isreali cannabis industry have been preparing for the opportunity to export product since last year and most operations have already built out the necessary infrastructure to support the mass export of cannabis out of the country. Those involved in the cannabis sector in Isreal believe its a matter of time before legislation opens up in their favor.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
270 views
Market Watch
270 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
194 views
Global
194 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
190 views
Manufacturing
190 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: